Liver Cancer: Related News

On Our Blog

Pictured: Scott Lowe
Researchers Uncover Potential Target for “Undruggable” Form of Liver Cancer

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.

September 30, 2014
Solutions for Chemotherapy-Related Nausea and Vomiting

With quick action and the help of the right medicine at the right time, chemotherapy-induced nausea and vomiting can often be prevented, says MSK Nurse Leader Corey Russell.

September 29, 2014
Pictured: Karen Brown & Ghassan Abou-Alfa
Liver Cancer Experts Discuss Advances in Managing Complicated Cases

Watch our liver cancer experts discuss the latest in screening, diagnosis, treatment, and research.

August 21, 2014
Pictured: William Jarnagin
New Information about Diagnosing and Treating Liver Cancer at Memorial Sloan Kettering

Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.

February 25, 2014
Pictured: Stephen Solomon
Poking Holes in Cancer — One Electric Current at a Time

Irreversible electroporation – a new, minimally invasive treatment that uses electric current to poke tiny holes in cell membranes – is showing promise against hard-to-treat tumors.

January 27, 2014
Pictured: Michael D’Angelica
Meet Surgeon Michael D’Angelica

Dr. D’Angelica – who treats patients with liver, pancreatic, and bile duct cancers – discusses the expertise of Memorial Sloan Kettering surgeons, who routinely perform complex procedures.

August 21, 2012

Related Media Coverage

Teen Makes Genetic Discovery of Her Own Rare Cancer

Pediatric Surgical Service Chief Michael LaQuaglia was interviewed about working with one of his teenage patients on a research project to genetically sequence tumors in patients with fibrolamellar hepatocellular carcinoma, a rare liver cancer.

April 16, 2014
Teen Helped Research Her Own Disease

Pediatric surgeon Michael La Quaglia worked with eighteen-year-old cancer survivor Elana Simon to identify a genetic abnormality that may be a cause of her cancer, called fibrolamellar hepatocellular carcinoma.

February 28, 2014